• TRADE NAMES: Apo-Famotidine; Duexis (Horizon); Durater; Famodil; Famoxal; Ganor; Gastro; Motiax; Mylanta AR; Nu-Famotidine; Pepcid (Valeant); Pepcidine; Pepdul; Sigafam
  • INDICATIONS: Duodenal ulcer, gastric ulcer, gastroesophageal reflux disease
  • CLASS: Histamine H2 receptor antagonist
  • HALF-LIFE: 2.5–3.5 hours

Investigated for treating COVID-19.

Duexis is famotidine and ibuprofen.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric